Basis of Presentation - Additional Information (Details) $ in Thousands			3 Months Ended
	Feb. 25, 2024 USD ($)	Jul. 07, 2023 shares	Mar. 31, 2024 USD ($) shares	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($) shares	Jul. 06, 2023 shares
Inventory [Line Items]
Stock split ratio, common stock		0.071
Common stock, shares authorized (in shares) | shares		107,142,857	107,142,857		107,142,857	1,000,000,000
Accumulated Deficit			$ 252,385		$ 255,659
Cash flows from operations			(3,339)	$ (9,374)
Cash and cash equivalents			18,397		$ 16,557
Aggregate gross proceeds			$ 30,000
Net proceeds from issuance of preferred stock and warrants	$ 9,250
Common Stock
Inventory [Line Items]
Reduction factor of authorized shares		1.5
Convertible preferred stock
Inventory [Line Items]
Reduction factor of authorized shares		1.5
Temporary equity, shares authorized (in shares) | shares		10,741,071	10,741,071		10,741,071	100,000,000